DIA Biosimilars 2013

Awards & Advancement

Nile Therapeutics appoints Darlene Horton as CMO

Friday, June 22, 2012 10:19 AM

Nile Therapeutics, a San Mateo, Calif.-based biopharmaceutical company that develops novel therapeutics for heart failure patients, has appointed Darlene Horton, M.D. as its chief medical officer.

More... »

Cenduit: Now with Patient Reminders

Trophos appoints Christine Placet as CEO

Monday, June 18, 2012 12:22 PM

Trophos, a French clinical stage pharmaceutical company developing therapeutics for under-served needs in neurology and cardiology, has appointed Christine Placet as chief executive officer.

More... »

CRF Health – eCOA Forum

Covance U.K. sites receive Carbon Trust Standard accreditation

Monday, June 18, 2012 11:44 AM

Covance, a provider of drug development services based in Princeton, N.J., has received Carbon Trust Standard accreditation in the U.K. for its commitment to measuring, managing and reducing energy consumption and carbon emissions. 

More... »

Saladax Biomedical names Harter president and CEO

Monday, June 18, 2012 11:35 AM

Saladax Biomedical, a Bethlehem, Penn.-based privately held company developing and commercializing novel diagnostic, has appointed Kevin M. Harter as president and chief executive officer.

More... »

Cell Therapeutics appoints Benner as new CMO

Friday, June 15, 2012 11:11 AM

Cell Therapeutics, a Seattle-based company focused on translating science into novel cancer therapies, has appointed former OncoMed Pharmaceuticals executive, Steven E. Benner, M.D., M.H.S., as its executive vice president and chief medical officer.

More... »

Seventh Sense Biosystems appoints Weisman as president and CEO

Thursday, June 14, 2012 12:21 PM

Seventh Sense Biosystems, a Cambridge, Mass.-based privately-held medical device company developing the novel Touch Activated Phlebotomy (TAP) painless blood sampling system, has appointed Howard Weisman as president, CEO and board member.  

More... »

Pacific Meso Center adds Wong to research team

Monday, June 11, 2012 03:42 PM

The Pacific Meso Center (PMC), a division of the Pacific Heart, Lung & Blood Institute focused on research and treatment of malignant pleural mesothelioma (MPM), has appointed Dr. Raymond M. Wong, PhD, as its new scientific researcher.

More... »

Kinsey joins Fraunhofer CSE as director of photovoltaic technologies

Friday, June 8, 2012 11:32 AM

The Fraunhofer Center for Sustainable Energy Systems (CSE), an applied contract R&D center of Cambridge, Mass., has hired concentration photovoltaics (CPV) expert Geoffrey S. Kinsey, Ph.D. to serve as the new director of its photovoltaic technologies group.

More... »

RxAlly adds Peter Duran to leadership team

Friday, June 8, 2012 10:57 AM

RxAlly, a performance network of 22,000 aligned pharmacies nationwide, has named Peter C. Duran vice president and chief privacy officer.

More... »

Abbott named as one of the 'Best Places to Work in Industry'

Tuesday, June 5, 2012 08:04 AM

Abbott Laboratories was once again named one of the "Best Places to Work in Industry" by The Scientist magazine, ranking No. 14 on the 2012 list. This is the ninth time that Abbott has been on the list since The Scientist first started ranking companies in 2003.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs